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Changes in the cis-regulation of neural genes likely contributed to the evolution of our species’ unique attributes, but
evidence of a role for natural selection has been lacking. We found that positive natural selection altered the cis-
regulation of human prodynorphin, the precursor molecule for a suite of endogenous opioids and neuropeptides with
critical roles in regulating perception, behavior, and memory. Independent lines of phylogenetic and population
genetic evidence support a history of selective sweeps driving the evolution of the human prodynorphin promoter. In
experimental assays of chimpanzee–human hybrid promoters, the selected sequence increases transcriptional
inducibility. The evidence for a change in the response of the brain’s natural opioids to inductive stimuli points to
potential human-specific characteristics favored during evolution. In addition, the pattern of linked nucleotide and
microsatellite variation among and within modern human populations suggests that recent selection, subsequent to
the fixation of the human-specific mutations and the peopling of the globe, has favored different prodynorphin cis-
regulatory alleles in different parts of the world.
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Introduction
Discovering the genetic changes that accompanied the
origins of modern humans and pinpointing the subset of
changes driven by natural selection remain central problems
in evolutionary anthropology. These changes are likely to
have included changes in the complement of genes, changes
in the amino acid sequences of proteins, and changes in cis-
regulation. While divergence in gene complement [1–4] and
amino acid sequence [5–9] are discernable from genome
sequences, functional divergence in cis-regulatory regions is
largely invisible in sequence data. Consequently, while we
now know of many uniquely human aspects of gene comple-
ment and protein sequence, we possess only a few docu-
mented examples of human-speciﬁc cis-regulation [10,11].
Moreover, while statistical tests for discerning the signature
of positive selection in protein-coding sequences are well
developed, and genomic surveys have identiﬁed many human
genes showing evidence of positive selection [12,13] or
diminished negative selection [14], in only a single instance
has positive selection been implicated in cis-regulatory
divergence between humans and other apes [15]. Our
ignorance of cis-regulatory divergence is all the more
remarkable considering the importance assigned to such
changes in models of evolutionary novelty [16–20]. Thirty
years have passed since King and Wilson [21] argued that
human evolution owes more to changes in gene regulation
than to changes in gene structure, and although their
theoretical justiﬁcations remain strong, empirical study of
human regulatory evolution has not kept pace [22].
An understanding of the genetic basis for human traits
necessarily focuses on the evolution of the brain. Inquiries
into human brain-speciﬁc gene regulation have relied on
phenotypic analyses, particularly microarray measurements
of gene expression in post-mortem human and ape brain
tissue. These analyses document extensive differences in gene
expression between humans and other great apes [23–26], but
the genetic basis of such differences—if any—remains
unknown. Moreover, a speciﬁc class of change in gene
regulation, change in transcriptional inducibility, is invisible
to studies of post-mortem tissues. Our species is distinguished
by the ability to respond to and manipulate environmental
cues; the responsiveness of genes to such cues, and not merely
their constitutive activity, may play a role in human
evolution.
Given the difﬁculties associated with identifying DNA
sequence changes responsible for changes in inducibility,
we focused on a candidate region whose role in inducibility in
humans has already been demonstrated. The a priori
designation of a functional regulatory element allows us to
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sequences—speciﬁcally, rate comparisons among classes of
nucleotide sites [20]. Of necessity, we also investigated the
functional consequences of the species differences exper-
imentally; we used transient transfection of promoter-
reporter constructs into cultured human cells, a method with
a record of success in identifying functional variation within
our species [27–30].
We studied the cis-regulatory evolution of the opioid
neuropeptide precursor prodynorphin (PDYN)( O M I M
131340). The opioid neuropeptides (endorphins) are the
endogenous ligands for the opiate receptors. They mediate
the anticipation and experience of pain [31,32], they
inﬂuence behaviors including social attachment and bonding
[32,33], and they affect learning and memory [32,34]. One of
PDYN’s products is dynorphin, a peptide whose pharmaco-
logical analogs speciﬁcally affect perception [35]. A 68 base-
pair (bp) tandem repeat polymorphism in the human PDYN
promoter, 1,250 bp upstream from the start of transcription,
inﬂuences the inducibility of the gene [36], and association
studies have tentatively implicated the polymorphism in
schizophrenia [37], cocaine addiction [38], and epilepsy [39].
These genetic associations are supported by physiological
associations between PDYN expression and each of the
phenotypes [40–42].
Results
Phylogenetic Evidence: Accelerated Evolution of a
Functional Element in the Human PDYN Promoter
To understand the evolutionary basis for the functional
variation, we sequenced 3 kilobases (kb) of PDYN regulatory
DNA from 74 human chromosomes and 32 chromosomes
from seven species of non-human primates, experimentally
determining haplotypic phase by cloning each allele. The
non-human primates bear a single copy of the 68-bp
regulatory element, and the pattern of substitutions implies
that the duplication of the element is speciﬁc to the human
lineage. All human copies of the element carry ﬁve
substitutions that differentiate them from the sequence
inferred for the last common ancestor of humans and
chimpanzees. A sixth difference is variable among repeats
in some human haplotypes (Figure 1).
The ﬁve substitutions ﬁxed on the human lineage are
dramatically more than expected for 68 bp of neutrally
evolving sequence. Under a model of spatially random
mutation, the expected number of substitutions is fewer than
0.5, and the observed number is extremely improbable
(Poisson p , 0.0001), whether we calculate the expectation
from the density of substitutions across the PDYN promoter,
the average divergence between human and chimpanzee on a
chromosomal scale [43], or the estimated great ape sub-
stitution rate [44].
The elevated number of substitutions may be due to locally
elevated mutation rate or to positive selection increasing the
probability of ﬁxation of new mutations. If the local mutation
rate is intrinsically elevated, other species should also exhibit
rapid evolution in the 68-bp region. We therefore tested a
molecular clock, using phylogenetic likelihood ratio tests [45],
to ask whether the 68-bp region is evolving rapidly due to an
elevated mutation rate. The evolution of the 68-bp element is
signiﬁcantly accelerated exclusively along the branch leading
to humans from our last common ancestor with chimpanzees
(p¼0.005). The other branches of the evolutionary tree show
no departure from rate constancy (p ¼ 0.657), and the
remainder of the promoter region and the coding sequence
of PDYN also show no acceleration (Table 1). To control for
possible lineage speciﬁc rate variation, we applied the relative
ratio test [46], which allows for lineage-speciﬁc rates and for
DNA region-speciﬁc rates, and tests for lineage-by-region
interactions. Here again, the human 68-bp repeat exhibits a
signiﬁcant departure from the neutral expectation (p ¼ 0.001
for proportionality to the rest of the promoter, p ¼ 0.015 for
proportionality to the coding sequence; Table 2); the
remaining lineages and regions exhibit no such departures.
The phylogenetic data imply that the rapid evolution of the
human 68-bp element is due to positive selection.
The molecular evolution of the PDYN protein sequence,
unlike the regulatory DNA, is consistent with a history
dominated by negative selection. In a sample of the complete
coding sequences from multiple chromosomes of eight
primate species, 25 of the 254 amino acids in the PDYN
protein vary, but none of the variants affect the 56 amino
acids that comprise the neuroactive peptides. The exclusion
of variation from the mature opioid peptides (Poisson p ¼
0.004) implies negative selection to maintain function.
Figure 1. Divergence of the 68-bp Element in Humans
Arrows indicate five differences fixed on the human lineage. The asterisk indicates a site that varies among human repeats. In the sample of 74 human
haplotypes, all one-repeat and most two-repeat alleles bear G at this site. Complete haplotype data are given in Table S1. Below, schematic of the study
region showing the position of the element and the non-coding first exon with respect to the start of transcription.
DOI: 10.1371/journal.pbio.0030387.g001
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PDYN EvolutionPhylogenetic likelihood ratio tests found no support for
positive selection shaping the amino acid sequence of the
remainder of the preprotein (model 1 versus model 2 of Yang
et al. [47], p ¼ 0.62). Nielsen et al. [13], in a genome scan of
human-chimpanzee orthologs, also found no evidence for
selection on the PDYN protein. No amino acid polymor-
phisms are known among humans, and we found none by
directly sequencing the coding regions from chromosomes
bearing each of the four repeat-number alleles of the
promoter.
Population Genetic Evidence: An Excess of High-
Frequency-Derived Mutations Flanking the Selected
Element
Positive selection alters the frequency spectrum of linked
neutral mutations. As the selected mutations are driven
rapidly to ﬁxation, linked alleles are dragged along to high
frequency [48]. The linked alleles may be dragged to ﬁxation,
but they may also be driven to high frequency and then
decoupled from the selected mutation by recombination or
allelic gene conversion. As a result, an excess of high-
frequency-derived mutations ﬂanking a ﬁxed difference
provides evidence for positive selection [49]. Our sample of
74 experimentally phased haplotypes from an Austrian
population exhibits such a pattern (Table S1). Fay and Wu’s
H statistic is  8.13, strongly supporting a departure from
neutrality and consistent with positive selection (p ¼ 0.004).
The three polymorphisms nearest to the 68-bp element have
derived allele frequencies greater than 0.95 in all repeat-
number allelic classes, consistent with a selective sweep that
ﬁxed mutations in the 68-bp region, and that thus predated
the origin of different repeat alleles by tandem duplication.
As the 68-bp element is tandemly repeated in all sampled
human populations (Table 3), the signature of selection in all
Austrian repeat-number allelic classes also implies that the
selective events predate the global human diaspora. A sample
of 20 chimpanzee haplotypes, though exhibiting many more
polymorphic sites than the human haplotypes, and hence
more power to detect a departure from neutrality, shows no
such departure (H ¼ 1.62).
The human-speciﬁc accelerated evolution of the 68-bp
element is best explained as the result of positive selection
favoring the ﬁxation of mutations. Although the rate is
elevated by a factor of more than ten over the neutral
expectation, the selection intensity required to explain this
excess is quite modest. The rate of substitution (k) is equal to
the rate at which new mutations arise in the population
(2Nem) times the probability that a new mutation will become
ﬁxed [50], which is 1/2Ne for neutral mutations and
approximately 2s for advantageous mutations in a population
Table 1. Molecular Clock Tests
Partition Model -lnL Test 2d df p
Repeat (68 bp) 0. Molecular clock 169.40 0 versus 2 11.34 6 0.078
1. Human branch free 165.37 0 versus 1 8.06 1 0.005
2. All branches free 163.73 1 versus 2 3.28 5 0.657
Remainder of promoter (3,008 bp) 0. Molecular clock 5,739.90 0 versus 2 6.82 6 0.338
1. Human branch free 5,739.89 0 versus 1 0.02 1 0.888
2. All branches free 5,736.49 1 versus 2 6.80 5 0.236
Coding sequence (765 bp) 0. Molecular clock 1,348.52 0 versus 2 9.08 6 0.169
1. Human branch free 1,348.51 0 versus 1 0.02 1 0.888
2. All branches free 1,343.98 1 versus 2 9.06 5 0.107
Phylogenetic log likelihoods are compared with and without molecular clock constraints, by means of a likelihood ratio test. Only the 68-bp element shows a departure from rate constancy, and the departure is due entirely to a human-
specific acceleration, as shown by the test comparing model 0 (molecular clock for all branches) to model 1 (molecular clock for all branches except the human branch). When the human specific acceleration is accommodated, the remaining
branches show no departure from rate constancy (test of model 1 versus model 2).
df, degrees of freedom
DOI: 10.1371/journal.pbio.0030387.t001
Table 2. Relative Ratio Tests
Comparison Model -lnL Test 2d df p
Repeat (68 bp) versus remainder of promoter (3,008 bp) 0. Relative ratio 5,908.60 0 versus 2 22.20 14 0.075
1. Human branch free 5,903.18 0 versus 1 10.84 1 0.001
2. All branches free 5,897.50 1 versus 2 11.36 13 0.581
Repeat (68 bp) versus coding sequence (765 bp) 0. Relative ratio 1,516.18 0 versus 2 22.38 14 0.071
1. Human branch free 1,513.20 0 versus 1 5.96 1 0.015
2. All branches free 1,504.99 1 versus 2 16.42 13 0.227
Remainder of promoter (3,008 bp) versus coding sequence (765 bp) 0. Relative ratio 7,089.80 0 versus 2 18.66 14 0.178
1. Human branch free 7,089.48 0 versus 1 0.64 1 0.424
2. All branches free 7,080.47 1 versus 2 18.02 13 0.157
Phylogenetic log likelihoods are compared with and without relative ratio constraints, by means of a likelihood ratio test. Only the 68-bp element shows a departure from rate proportionality, and the departure is due entirely to human-
specific acceleration. The relative ratio test asks whether the branch-specific evolutionary rates of two data partitions are proportional. The tests involving the 68-bp element reject rate proportionality for the human branch (test of model 0
versus model 1), but not for the remaining branches of the tree (tests of model 1 versus model 2). The remainder of the promoter and the coding sequence exhibit proportional rates of evolution, consistent with neutrality.
df, degrees of freedom
DOI: 10.1371/journal.pbio.0030387.t002
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PDYN Evolutionof constant size [51], where Ne is the effective population size,
l is the mutation rate, and s is the selective advantage of the
mutant allele. If we let fa be the fraction of non-deleterious
mutations in the 68-bp element that are advantageous, then
the rate acceleration (kobserved/k neutral) is the ratio of the
substitution rate in the human 68-bp element ([1   fa]l þ
4Neslfa) to that expected in the absence of positive selection
(l). We can place bounds on fa by recognizing that there are
only 204 base-substituting mutations possible in a 68-bp
sequence. For the usual estimate [52] of long-term human
effective population size, Ne ¼ 10,500, s falls in the range
0.0002 to 0.045; for fa greater than 2.2% (e.g., if all ﬁve ﬁxed
mutations were advantageous) s is less than 0.01 (Figure S1),
well below the estimated selection coefﬁcients of lactase
persistence in Northern Europe [53] and G6PD deﬁciency
[54] in regions of endemic malaria.
Functional Evidence: The Selected Element Increases
Inducible PDYN Expression
To determine the effect of the selected nucleotide
substitutions on PDYN transcription, we transiently trans-
fected the human neural cell line SH-SY5Y with constructs
bearing 3 kb of human or chimpanzee PDYN cis-regulatory
DNA linked to a luciferase reporter. Downstream of the 68-
bp repeat, in the non-coding ﬁrst exon of PDYN,i sa
downstream regulatory element (DRE), a binding site for the
repressor protein DRE-antagonist modulator (DREAM) [55].
A single nucleotide substitution in humans alters the DRE
from the sequence found in the other primate species. To
isolate the effect of the substitutions in the 68-bp element
from the effect of the substitution in the DRE, we generated
chimeric constructs containing either the human DRE or the
human 68-bp element in the context of the chimpanzee
promoter (Figure 2).
We found that the human DRE sequence conferred slightly
elevated expression of the reporter under basal conditions,
though the effect was not signiﬁcant (Figure 2B; analysis of
variance p¼0.11). The sequence of the 68-bp element has no
effect under these conditions (p ¼ 0.66). When the effect of
DREAM is removed by stimulating the cells to release
intracellular Ca
2þ, which binds DREAM and causes it to
release from DNA, the effect of the substitutions in the 68-bp
element is conspicuous. Under these conditions, the human
68-bp element drives signiﬁcantly higher expression than the
chimpanzee sequence, regardless of the source of ﬂanking
sequence (Figure 2B; p ¼ 0.002). Each relevant pairwise
Figure 2. The Human 68-bp Element Increases Induced PDYN Expression
We tested four 3-kb constructs, encompassing the region shown in Figure 1.
(A) The human and chimpanzee constructs differ at the sites indicated by vertical bars. The two chimeric constructs incorporated the human 68-bp
element or the human DRE (DREAM binding site) into the chimpanzee construct.
(B and C) Panels show luciferase activity for each construct (6 SEM, five to seven transfections), standardized to that observed for promoterless
luciferase vectors (white bars), in SH-SY5Y and JAR cells, with and without added caffeine, which causes the release of intracellular Ca
2þand the release
of DREAM from the DRE.
DOI: 10.1371/journal.pbio.0030387.g002
Table 3. PDYN Repeat Allele Frequencies
Sample N
a 1234
Cameroon 82 0.02 0.61 0.35 0.01
China 76 0.03 0.88 0.09 0
Ethiopia 90 0 0.32 0.68 0
India 84 0.01 0.63 0.36 0
Italy 88 0.01 0.35 0.64 0
Papua New Guinea 90 0 0.98 0.02 0
aNumber of chromosomes sampled.
DOI: 10.1371/journal.pbio.0030387.t003
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PDYN Evolutioncontrast is signiﬁcant by t-test (human versus chimpanzee,
120%, p ¼ 0.006; chimpanzee with human element versus
chimpanzee, 115%, p¼0.037; human versus chimpanzee with
human DRE, 120%, p ¼ 0.007). In a three-factor analysis of
variance, incorporating Ca
2þ stimulation and the sequences
of the DRE and the 68-bp element, the main effects of Ca
2þ (p
, 0.001) and the 68-bp element (p¼0.011) are signiﬁcant and
the interaction between Ca
2þ and the 68-bp element is nearly
signiﬁcant (p ¼ 0.054).
In contrast to the SH-SY5Y results, we observed no
difference between chimpanzee and human constructs in
the non-neural JAR cell line (Figure 2C), which serves as a
control for the biological relevance of the cis-regulatory
differences. Because PDYN is expressed in a broad range of
neural and endocrine cell types and is induced by a diverse
array of stimuli, our limited survey of potential functional
consequences of human-speciﬁc regulatory substitutions is
unlikely to have identiﬁed all such changes. Although
transient transfection entails the removal of the regulatory
DNA from its chromosomal context and the possible loss of
biologically important interactions, the experimental results
imply that the substitutions in the 68-bp element are visible
to the cell.
Continuing Selection: PDYN Exhibits Elevated
Differentiation among Populations and Reduced Variation
within Them
The evidence for positive selection on the functional 68-bp
element, and hence for increased PDYN expression in
humans, raises the possibility that selection has also acted
more recently on the alleles that differ in the number of
tandem repeats of the element following the origin of
modern humans. Intraspeciﬁc PDYN variation is a plausible
target for selection because variation in the number of
repeats has been shown to affect inducibility by the phorbol
ester TPA [36] and has been associated with protection
against cocaine dependency [38] and with neurological
disease [37,39]. Moreover, evidence for selection among
human populations would corroborate the functional im-
portance of the 68-bp element, and hence support the
inference of selection in human origins.
Population genetics predicts that recent selection in
human populations will leave two types of signatures in
patterns of genetic variation: departures from neutral
expectations in the pattern of differentiation among pop-
ulations, and departures from neutral expectations in the
pattern of variation within populations. These predictions
have given rise to a battery of statistical tests: FST -based tests
to examine differentiation among populations, and h-based
tests to examine diversity within populations [56].
We initially genotyped the repeat polymorphism in six Old
World populations and compared differentiation among
populations (measured by FST) at the repeat locus to the
differentiation expected at loci evolving neutrally. Elevated
FST is a signature of geographically heterogeneous positive
selection, driving allele frequencies to differ among popula-
tions more rapidly than they would if genetic drift and
migration only were acting [57]. We estimated the neutral
distribution of FST values from a set of 18 mutually unlinked
candidate neutral single nucleotide polymorphisms (SNPs)
typed in the same individuals [58]. Each of the candidate
neutral SNPs was selected for this preliminary screening on
the basis of its high heterozygosity in Europe and its distance
(more than 200 kb) from known genes. FST values are
constrained by the overall level of variation at a locus, so
high heterozygosity is a useful ﬁlter for a pool of informative
marker SNPs. Similarly, because genes and their regulatory
elements are more likely to be under selection than arbitrary
non-coding DNA, SNPs distant from genes are good
candidates for neutral mutations.
Alleles with one or four copies of the PDYN repeat element
are rare in every population we examined, but the frequen-
cies of the two- and three-repeat alleles differ dramatically
among populations (Table 3). The three-repeat allele ranges
in frequency from less than 10% in China and New Guinea to
more than 60% in Italy and Ethiopia. The differentiation at
the repeat locus is higher than all 18 neutral markers for four
of ﬁfteen pairwise comparisons (Table 4), and the degree of
elevation is substantial (Figure 3A-D). Although the small
number of loci in our neutral proxy dataset makes it difﬁcult
to estimate precise signiﬁcance values, we may approximate a
denser probability distribution by bootstrapping over loci
[58]. In this test, the difference between the PDYN FST and the
18-locus estimate of FST is signiﬁcantly higher than the
bootstrapped differences (p , 0.001) in the four comparisons.
Moreover, PDYN has the second or third highest FST in four
more comparisons; the sum of FST ranks across all 15
comparisons is signiﬁcantly low (p ¼ 0.01), although this p-
value cannot be taken at face value due to the non-
independence of the pairwise comparisons.
If the elevated FST at PDYN is due to positive selection
favoring different alleles in different populations, the
signature of selection should also be visible in nearby
variants, whose evolutionary fates are tied to the selected
variant by linkage. We therefore asked whether the PDYN
locus falls within an extended region of elevated FST.W e
investigated only Chinese-European FST,t h ep o p u l a t i o n
contrast for which our data suggested elevated FST (Figure
3A) and for which a genomic dataset was available. We used a
dataset of 1,236,401 autosomal SNPs genotyped in African-,
European-, and Chinese-Americans [59]. Because SNP ascer-
tainment can inﬂuence the distribution of polymorphism
statistics, we limited ourselves to SNPs ascertained by a single
scheme: speciﬁcally, array-based resequencing of chromo-
somes from the National Institutes of Health Polymorphism
Discovery Resource, a global sample. Because the 1.2 million
SNPs share a common ascertainment bias, variation in FST
Table 4. Pairwise FST at PDYN and at Neutral Markers
Sample Cameroon China Ethiopia India Italy Papua
New Guinea
Cameroon — 0.16 0.16 0 0.12 0.30
China 0.13 — 0.50 0.15 0.45 0.19
Ethiopia 0.05 0.05 — 0.17 0 0.67
India 0.10 0.03 0.02 — 0.13 0.30
Italy 0.12 0.08 0.04 0.03 — 0.59
Papua New Guinea 0.33 0.18 0.25 0.22 0.30 —
FST at the PDYN 68-bp element appears above the diagonal, and FST at candidate neutral loci appears below the
diagonal.
DOI: 10.1371/journal.pbio.0030387.t004
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PDYN EvolutionFigure 3. Elevated Differentiation at PDYN
(A–D) In four pairwise comparisons, FST at the PDYN 68-bp element (red) is markedly elevated above the FST estimated from 18 candidate neutral
markers (blue) typed in the same individuals.
(E) Genetic differentiation between European- and Chinese-Americans, measured as a 15-SNP running FST average, for the entire p-arm of Chromosome
20. PDYN falls under a large FST peak (shaded), high above the arm average (red line). The RefSeq and chromosome band annotation is from the
University of California, Santa Cruz Human Genome Browser (hg17), http://genome.ucsc.edu [79]. Perlegen SNP positions were matched to the hg17
assembly by the UCSC LiftOver utility.
(F) A finer-scale sliding window analysis shows that the region of elevated FST includes only two genes, PDYN and STK35, shown according to their
RefSeq annotations.
(G) FST as a function of expected global heterozygosity. Red triangles represent the 52 SNPs in the Perlegen dataset in the 170-kb interval bounded by
the 39 ends of PDYN and STK35. The contours define the genome-wide density of FST conditioned on heterozygosity; for each heterozygosity, the lines
represent the FST of SNPs in the specified FST percentile.
DOI: 10.1371/journal.pbio.0030387.g003
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PDYN Evolutionalong the chromosomes will reﬂect only variation in the
demographic and selective history of genomic regions.
As an initial screen, we generated a 15-SNP sliding window
plot of FST, considering only SNPs whose expected global
heterozygosity exceeds 0.30. This ﬁlter is necessary to remove
the dependence of FST on heterozygosity; otherwise, the plot
would primarily reﬂect variation in the allele frequencies of
the genotyped SNPs rather than differentiation among
populations. As Figure 3E shows, PDYN falls within a tall
and broad peak in FST. A ﬁner scale sliding window plot
(Figure 3F) indicates that the region of elevated FST
encompasses two genes, PDYN and a serine/threonine kinase
(STK35) implicated in cytoskeletal regulation [60]. These
genes are divergently transcribed, and their intergenic region
therefore likely contains the majority of cis-regulatory DNA
for both genes. The 39 ﬂanking regions of each gene also
exhibit elevated FST.
The genome-wide empirical distribution of FST is shaped by
both demography and selection, and therefore the tail
probabilities of SNPs estimated from the empirical distribu-
tion represent a very conservative test for selection. Never-
theless, the SNPs within the PDYN-STK35 FST peak exhibit
signiﬁcantly elevated FSTs. In Figure 3G, we plot FST versus
expected global heterozygosity for all 52 genotyped SNPs in
the 170-kb interval deﬁned by PDYN and STK35 (i.e.,
excluding the 39 ﬂanking SNPs). We also plot the contours
of the genome-wide FST distribution conditioned on hetero-
zygosity; note that the median FST is below 0.06 for all
heterozygosities. Six of the 52 SNPs in this region (12%) have
FSTs in the top 0.5% of the genome-wide distribution, and 20
of the 52 (38%) are in the top 5%.
The number and location of selected variants driving
elevation of FST remain unclear. However, neither PDYN nor
STK35 is known to contain any non-synonymous variants,
and neither protein sequence exhibits evidence of positive
selection during human evolution [13]. The target or targets
of selection are therefore likely to be cis-regulatory and to
include the alleles of the 68-bp element.
Positive selection driving differentiation between popula-
tions should also decrease variation within populations; as a
selected allele increases in frequency, its haplotype replaces
other haplotypes before accumulating new variation. Micro-
satellites are particularly sensitive monitors of linked
selection because of their high levels of polymorphism and
high mutation rate. We asked whether the microsatellite
nearest the PDYN promoter 68-bp element, a (CA)13–27
dinucleotide microsatellite 1.3 kb further upstream, exhibits
the predicted signatures of selection. We genotyped the
microsatellite in our panel of six populations (Figure 4A), and
we used repeat-number variance and expected heterozygosity
as summary statistics (Table 5).
Repeat-number variance and heterozygosity are functions
of h ¼ 4Nel [61]. Because microsatellites vary in their
mutation rates (l) and recombinational contexts (which
inﬂuences Ne), we used test statistics that control for these
effects. For a given microsatellite, mutation rate and
recombinational context are expected to be shared among
populations, so they cancel out in a ratio. The ratio, Rh,
therefore estimates the relative effective sizes of two
populations controlling for locus-speciﬁc phenomena; re-
maining variation among neutral microsatellites is attribut-
able to stochastic variation in the outcomes of a neutral
Figure 4. Altered Variation at the PDYN Microsatellite
(A) The allele frequency distribution of the PDYN microsatellite for six
populations. The most common allele has 18 CA repeats in each
population except Papua New Guinea, where the 22-repeat allele is most
common; the overall range is 13 to 27 repeats. The distributions show a
reduction in allelic variation outside of the Cameroon population.
(B) The empirical probability density of lnRV for a panel of genomically
distributed microsatellites is plotted for each population, using panel A
as the color key. The distributions are based on 193 microsatellite loci for
Ethiopia and 377 loci for the other populations. For clarity, a single
negative outlier from the New Guinea population has been omitted from
the figure. The arrows indicate lnRV of the PDYN microsatellite for each
population, in the left tails of the distributions, indicating a locus-specific
reduction in repeat-number variance.
(C) The empirical probability density for lnRH. Again, the PDYN
microsatellite exhibits significantly negative lnRH values, indicating a
locus-specific reduction in heterozygosity at PDYN in the non-West
African populations.
DOI: 10.1371/journal.pbio.0030387.g004
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PDYN Evolutioncoalescent process [62,63]. Positive selection in one popula-
tion will reduce heterozygosity and repeat-number variance
at a linked microsatellite, causing it to appear in the tails of
the estimated distributions of lnRV and lnRH (where repeat-
number variance and heterozygosity are used in place of h).
We estimated lnRh distributions empirically from a
genome-wide dataset of 337 autosomal loci [64, 65]. Because
our FST data do not indicate recent selection in the sample
from Cameroon, we used Cameroon as the denominator in all
ratios, and we tested for positive selection in the other
populations. Those in which positive selection has acted are
predicted to exhibit signiﬁcantly negative lnRh at the PDYN
microsatellite, unless the Cameroon sample has experienced
equal or more extreme positive selection at a PDYN-linked
locus.
We found a signiﬁcant reduction in repeat-number
variance at the PDYN microsatellite (Figure 4B) in three
populations (Italy, p¼0.031; India, p¼0.034; China, p¼0.021),
but not in Ethiopia (p ¼ 0.103) or Papua New Guinea (p ¼
0.209). The sum of lnRV ranks across populations places
PDYN in the 2.5% tail of lowest sums among all the
microsatellites. The reduction in heterozygosity at PDYN
(Figure 4C) is even more extreme (p , 0.003 for Italy and
India, p , 0.006 for Ethiopia, p ¼ 0.016 for China, and p ¼
0.072 for Papua New Guinea). The PDYN microsatellite is the
locus with the lowest lnRH rank summed over populations.
The relationship between the events reducing variation at
the PDYN microsatellite and the events elevating FST at the
68-bp repeat is most obvious when the haplotypic phase
between the two elements is considered. We calculated
expected heterozygosity and repeat-number variance in
subsets of our experimentally determined haplotypes from
an Austrian population. As shown in Table 5, the overall
reduction in microsatellite heterozygosity and repeat-num-
ber variance is driven by the rapid elevation in frequency of
the three-repeat allele at the 68-bp element.
The combination of elevated FSTs and reduced lnRhs
implies that the selection occurred in multiple populations,
favoring the two-repeat allele in China and India, and the
three-repeat allele in Italy and Ethiopia. However, it remains
possible that the 68-bp element in the PDYN promoter is not
itself the target of selection, as the entire PDYN-STK35 region
bears the signature of recent positive selection.
Discussion
The phylogenetic and population genetic data described
above are difﬁcult to reconcile with a simple selective
scenario. Instead, they point to a complex selective history
at the human PDYN locus, with ancient positive selection
acting across the species and more recent positive selection
favoring different alleles in local contexts.
The data allow us to construct a coherent and plausible
model that accounts for each observation. During the course
of human descent from our last common ancestor with
chimpanzees, multiple non-coding mutations arising up-
stream of the start of PDYN transcription altered the gene’s
cis-regulation and swept to ﬁxation due to positive selection,
as indicated by analysis of the primate sequence data and the
elevated frequency of derived alleles ﬂanking the ﬁxations.
Concurrently, mutations altering the neuroactive peptide
products of PDYN were eliminated by negative selection. The
proximate effect of the ﬁxed cis-regulatory mutations is the
upregulation of PDYN transcription, particularly when
induced by intracellular calcium release. Subsequent to the
selective sweeps, but prior to the peopling of the globe, the
68-bp region encompassing the ﬁxed mutations duplicated.
The timing of these events is supported by the presence of the
ﬁxed differences on all copies of the repeat, the high
frequency of ﬂanking derived mutations in all repeat-number
allele classes, and the presence of the duplication in all
sampled human populations. The duplication segregates
today as a tandem repeat polymorphism, with one to four
repeats. After the global human diaspora, human populations
in different parts of the world experienced different regimes
of selection on PDYN cis-regulation, as indicated by the
elevated FST values. Selection drove an increase in the
frequency of the three-repeat allele in Europe and East
Africa and independently increased the frequency of the two-
repeat allele in India and China, according to the signiﬁcantly
reduced lnRh values in each of the populations implicated by
the FST data.
The convergence of independent lines of evidence—
phylogenetic, population genetic, and functional evidence
for ancient selection, and evidence of recent selection in
patterns of variation within and among modern human
populations—underscores the importance of PDYN to human
biology. Though PDYN has received little attention from
human geneticists, our evolutionary genetic data suggest that
the locus would repay further investigation. While we may
point to possible environmental and cultural agents of recent
selection, including differences in use of plant opiates and
environmental inducers of endogenous opioids, such as
acupuncture [66], the phenotype targeted by the ancient
selection is unknown.
For thousands of years, people have used opiates to alter
consciousness and ameliorate pain. Our data indicate that
the evolution of our species involved changes in the
inducibility of an endogenous opioid precursor, and that
these changes were driven by positive natural selection.
Changes in neuropeptide expression are known to have
accompanied behavioral evolution in other species [67,68],
but the difﬁculties in studying such changes in gene
expression in living human brains have prevented their
discovery until now. PDYN, a natural candidate for human-
speciﬁc traits by virtue of its documented role in perception,
Table 5. PDYN Microsatellite Summary Statistics
Sample Sample Size E(H) Var
Cameroon 76 0.836 7.97
China 78 0.424 1.44
Ethiopia 84 0.578 4.29
India 88 0.407 2.67
Italy 88 0.289 2.33
Papua New Guinea 88 0.553 2.67
Austria 1-repeat haplotypes 10 0.533 6.67
Austria 2-repeat haplotypes 24 0.605 4.72
Austria 3-repeat haplotypes 32 0.121 0.06
Austria 4-repeat haplotypes 8 0 0
Chimpanzee 20 0.853 6.24
DOI: 10.1371/journal.pbio.0030387.t005
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PDYN Evolutionemotion, nociception, and learning is the ﬁrst documented
instance of a neural gene whose cis-regulation has been
shaped by positive selection during human origins. Although
the transcriptional effects of the selected changes in the
PDYN promoter appear to be subtle, slight changes in gene
expression are capable of substantial effects on organismal
phenotypes [69]. In keeping with the predictions of King and
Wilson [21], our data imply that minor changes in gene
regulation played a signiﬁcant role in the evolution of the
traits that make us human.
Materials and Methods
Cloning and sequencing. Our human haplotypes are from an
anonymized collection of genomic DNA samples from an Austrian
population [39]. To guarantee recovery of rare one- and four-repeat
alleles, we selected DNAs of known repeat-number genotype (note
that representative samples were chosen for population genetic
analyses, described below). We PCR ampliﬁed 3-kb fragments of
PDYN promoter from genomic DNA, using high-ﬁdelity Phusion
polymerase (Finnzymes, Espoo, Finland). For repeat-number hetero-
zygotes, PCR products were cloned into pGL3-basic vector, using an
invariant Acc65I site at the 59 end of the promoter and a NheI site
incorporated into the PCR primer at the 39 end. For each haplotype,
we completely sequenced multiple clones, and all singletons were
veriﬁed by bidirectional direct sequencing. Repeat-number homo-
zygotes were sequenced directly from PCR products; in cases of
multiple-site heterozygosity, these PCR products were also cloned
and multiple clones sequenced to determine phase. Non-human
primate DNA was acquired from Coriell Repositories (Camden, New
Jersey, United States) (Pan troglodytes, Pan paniscus, Gorilla gorilla, Pongo
pygmaeus, Macaca nemestrina, and Macaca mulatta), and as gifts from A.
Stone (Pan troglodytes and Pan paniscus), and D. Loisel (Papio papio). For
each sample, Phusion PCR products were cloned and sequenced as
above. We sequenced the two coding exons directly from PCR
products. In addition to non-human primates, we included four
Austrian samples with known promoter repeat genotype to ensure
recovery of coding sequence linked to each repeat-number allele.
Sequences were scored using Sequencher (GeneCodes Corporation,
Ann Arbor, Michigan, United States).
Phylogenetic and population genetic analyses. For all tests of
substitution densities and rates, we conservatively assume that the site
segregating among human repeat alleles represents a new mutation
within humans and not a sixth ﬁxed difference between humans and
chimpanzees. To calculate the Poisson probability of ﬁve substitu-
tions in 68 bp on the human branch, we found the expectation by
considering the local average substitution rate, the genomic average
divergence from chimpanzees, or the estimated genomic average
mutation rate. The local average substitution rate, estimated from the
human branch length for the entire 3-kb promoter sequence,
including the 68-bp element, yields an expectation of 0.46 sub-
stitutions per 68 bp. At the broader scale of whole chromosomes,
human and chimpanzee differ by nucleotide substitutions at an
average of 1.44% of sites [43]; if one half of the divergence occurred
on the human branch, the expected number of substitutions per 68
bp is 0.49. If instead of divergence, we consider the germline
mutation rate, estimated at 0.99 3 10
 9 per site, and assuming 5 to 7
million years of evolution since the last common ancestor of humans
and chimpanzees [44], we expect 0.34 to 0.47 substitutions per 68 bp.
Note that none of the substitutions occurs in a CpG context, although
CpG may have been an intermediate in the adjacent substitutions
that changed CpA in non-human primates to GpG in humans. The
ﬁve substitutions are C!G, A!G, A!G, T!C, and C!A, three
transitions and two transversions.
Molecular clock and relative ratio tests were implemented in
HYPHY (http://www.hyphy.org) using an eight-sequence dataset, with
a single allele representing each species. As our human exemplar we
used the most common one-repeat haplotype from our sample of ten
Austrian one-repeat alleles; we chose a one-repeat haplotype to
facilitate comparison with the one-repeat sequences of non-human
primates. The most common chimpanzee haplotype represented that
species, while for other species, because each haplotype is unique in
our small sample, a haplotype was selected randomly. Molecular clock
tests used best-ﬁt time reversible substitution models selected using
ModelTest [70]. For the coding sequence and the promoter excluding
the repeat, the favored model is HKY with C-distributed among-site
rate variation. We used the maximum likelihood-estimated transition/
transversion ratio and rate variation shape parameter and empirical
base frequencies. For the repeat, the favored model is K2P. The
relative ratio tests were performed using the HKY þ C model, but
results with K2P are very similar.
Negative selection on neuropeptides was tested by calculating the
Poisson probability that zero of 25 variable positions would fall in
the 56 of 254 amino acids comprising the neuropeptides. To test for
positive selection in the remainder of the protein, we compared
models 1 and 2 (2d ¼ 0.24364, p ¼ 0.62) and models 7 and 8 (2d ¼
0.0001, p ¼ 0.99) from Yang et al. [47], in HYPHY, using the
Goldman-Yang parameterization with base frequencies independent
of codon position. The dataset included one sequence from each
species.
For haplotype-based tests, we generated a representative popula-
tion sample [71] by drawing 74 haplotypes from the sequenced
Austrian haplotypes according to the population frequency of the
different repeat-number alleles [36]. Summary statistics and their p-
values were found using DNAsp [72].
Intensity of selection. Estimation of the rate acceleration factor (A)
involves three data partitions whose evolution is consistent with
neutrality. First, we found the maximum likelihood estimate of the
ratio of substitution rates between the 68-bp element and the
remainder of the promoter, excluding the human lineage (ratio ¼
1.804). Next, we estimated the substitution rate on the human lineage
for the portion of the promoter excluding the 68-bp element (rate ¼
0.00506 substitutions per site), holding the substitution model
parameters constant. The product of these gives the expectation
for the human 68-bp repeat under neutrality, 0.00913 substitutions
per site. (Note that the Poisson probability of ﬁve substitutions, given
that expectation, is 0.00005, and three or four mutations also fall in
the 0.025 tail of the Poisson probability.) The maximum likelihood
estimate of the substitution rate in the 68-bp element along the
human lineage, 0.0926 substitutions per site, represents an accel-
eration factor A ¼ 10.1. All estimates employed the HKY þ C
substitution model.
The genic selection coefﬁcient s is estimated from the relations
A ¼ð lð1   fd   faÞþ4NeslfaÞ=ðlð1   fdÞÞ and fa þ fd þ f0 ¼ 1, where fa,
fd, and f0 are the fraction of mutations that are advantageous,
deleterious, and neutral, respectively. Figure S1 shows s as a function
of the nuisance parameters fa and fd. We make the approximating
assumption that fa,f d, and f0 are constant over the course of the
selective history of the locus.
To convert the acceleration factor to s, we consider the case of
sequential ﬁxations and ignore the effect of interference among
independent advantageous mutations. The effect of interference is
likely to be modest, as the expectation of the conditional ﬁxation
time of advantageous alleles, ;(2/s)(ln2N) [73], is less than 10,000
generations for s . 0.002, while the time available for ﬁxations is
roughly 300,000 generations (6 million years, 20 years per gener-
ation). Our estimate of s is based on the long-term effective
population size since the divergence of humans and chimpanzees,
which may be much larger than the estimate for modern humans.
Larger Ne translates into even lower estimates of s. The ﬁxation
probability (;2s for constant Ne) is sensitive to ﬂuctuations in
effective population size [74], increasing during population expan-
sions and decreasing during bottlenecks. Our simple approach
assumes constant effective size.
The magnitude of the estimated rate acceleration excludes non-
reciprocal exchange processes subsequent to duplication (e.g., gene
conversion and unequal crossing-over) as possible explanations for
the human-speciﬁc acceleration. Unbiased non-reciprocal ex-
changes do not alter substitution rates; although the number of
sites available to mutate is increased by the number of repeat
elements (n), the probability that a new mutation will spread
among the repeats is 1/n. Biased processes can accelerate
substitution [75], but only when the bias consistently favors new
mutations over ancestral alleles. Even in the most extreme case,
where every inter-repeat conversion event replaces an ancestral
allele with a new mutation, the maximum rate acceleration is n. In
human PDYN, n averages less than three and never exceeds four,
and the long-term effective number of repeats (the harmonic mean
of repeat number over the duration of the human lineage) is likely
quite close to one. Strong bias is at any rate ruled out by the
presence of a segregating variant among the repeats. So non-
reciprocal exchange cannot produce the observed acceleration
factor under neutrality. Under positive selection, however, tandem
repeats, with or without biased conversion, can increase the power
of deterministic forces relative to drift by increasing the effective
population size to Nen [76].
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PDYN EvolutionVectors, cell culture, and transfection. We used the pGL3basic
luciferase reporter (Promega, Madison, Wisconsin, United States).
Chimpanzee and human constructs were generated as described
above (‘‘Cloning and sequencing’’). To generate chimeric constructs
with DRE site swaps, we cut the inserts with BstAPI and exchanged
the DRE-containing fragments. To generate a 68-bp element chimera,
we excised a human repeat using BspHI and DrdI and inserted it into
a chimpanzee vector in the equivalent position. Vectors were veriﬁed
by sequencing. We cultured JAR choriocarcinoma cells in RPMI 1640
with 2 mM L-glutamine and 10 mM HEPES, supplemented with 10%
FBS. SH-SY5Y neuroblastoma cells were cultured in a 1:1 mixture of
Ham’s F-12 and EMEM with 1 mM sodium pyruvate and 0.1 mM non-
essential amino acids, supplemented with 10% FBS. Both cell lines
were acquired from ATCC and maintained at 37 8C with 5% CO2.W e
performed transfections in 24-well plates with JAR cells at 90%
conﬂuence and SH-SY5Y cells at 50% conﬂuence. The transfection
mix, in OPTI-MEM, included 2 ll of Lipofectamine2000, 0.72 lgo f
pGL3, and 0.08 lgo fRenilla-TK (Promega) as a co-reporter to control
for variation in transfection efﬁciency. At 26 h, medium was
supplemented with growth medium with or without caffeine (ﬁnal
concentration 10 mM). Cells were harvested 16 h later. Luciferase
activity was measured using the Dual-Luciferase Reporter Assay
System (Promega) and a Turner Designs 20/20 luminometer. Results
are reported as ratios of ﬁreﬂy:Renilla luciferase, standardized by
setting the pGL3-basic ratio to one. Lysates from mock transfected
cells were used to blank for machine background. All transfections
were performed ﬁve to seven times, and effects assessed by analysis of
variance and pairwise t-tests.
FST and lnRh analysis. For the six-population analysis of FST,
neutral markers, DNA samples, FST calculations, and bootstrap
resampling are as previously described [58]. We genotyped the 68-
bp repeat and the PDYN microsatellite by scoring the length of
labeled PCR products run on an ABI 3700 capillary gel machine. We
veriﬁed genotypes for 10% of samples by direct sequencing of PCR
products.
Analysis of Perlegen data was limited to autosomal SNPs
ascertained according to scheme A of Hinds et al. [59], array-based
resequencing of National Institutes of Health Polymorphism Discov-
ery Resource chromosomes. SNP data were downloaded from http://
genome.perlegen.com/browser/download.html, and we used Perle-
gen’s precalculated FST values. To calculate expected global hetero-
zygosity, we averaged the allele frequencies for the three genotyped
populations and used 2p-2p
2, where p is the average frequency of the
global minor allele. To generate the percentile plot for FST
conditioned on expected heterozygosity, we sorted the SNPs into
ten bins, each covering ﬁve percentage points of expected global
heterozygosity range, we ranked SNPs within bins by FST, and then we
recovered the FST for the SNP whose rank coincides with the relevant
percentile within that bin. In Figure 3G, the contours are connecting
the data points for the ten bins for each percentile; e.g., the point
where the contours hit expected heterozygosity 0.5 represents the FST
percentile for SNPs with heterozygosities 0.45 to 0.5.
Microsatellite data were downloaded from N. Rosenberg’s Web
site, http://www.cmb.usc.edu/people/noahr/diversity.html, in structure
format. The Rosenberg data lacked a population to match to our
Ethiopian population, but data for 193 of the 377 loci were available
from the dataset of Kayser et al. [65]. To represent our populations,
we selected the populations in the Rosenberg data that are
geographically coincident or proximate. As the distributions are
quite similar for all populations (Figure 4B and 4C), the precision of
population matching appears unimportant (also found by [65]). We
selected as follows from the Rosenberg et al. data: Cameroon:
Yoruba; China: Han Chinese; India: pooled samples from the
populations included in Rosenberg et al.’s South Asia cluster,
speciﬁcally Brahui, Balochi, Hazara, Makrani, Sindhi, Pathan, and
Burusho; Italy: pooled samples from Sardinia, Tuscany, and Bergamo;
Papua New Guinea: Papuan. For each microsatellite locus, expected
heterozygosity was calculated as ð n
n 1Þ
PK
i¼1ð1   p2
kÞ, where n is the
number of chromosomes sampled, K is the number of alleles, and pk
is the frequency of the kth allele. Repeat-number variance was
calculated as
1
n   1
   X n
i¼1
x2  
ð
X n
i¼1
xÞ
2
n
0
B B B @
1
C C C A
;
where x is the number of repeats in the nth chromosome.
The statistical properties of lnRV and lnRH allow us to estimate
signiﬁcance values in a parametric context, reducing the inﬂuence
of any non-neutral outliers in the tails of the empirical
distribution. Each of the ﬁve lnRV distributions is consistent with
normality, according to a Kolmogorov-Smirnov test. Standardizing
our observed test statistics according to the empirical mean and
standard deviation, and using the tail probabilities of the standard
normal distribution, we recover p-values nearly identical to those
drawn from the empirical distribution (Italy: 0.034; India: 0.035;
China: 0.016; Ethiopia: 0.119; Papua New Guinea: 0.236). Of the
lnRH distributions, only the Ethiopian sample conforms to
normality according to the Kolmogorov-Smirnov test, conferring
a parametric p-value of 0.0002 on the Ethiopian PDYN micro-
satellite.
The causes of the departures of lnRH from normality are unclear,
but ascertainment bias is an obvious possibility. The 377 micro-
satellites were ascertained in a European population and may be
biased against microsatellites with low heterozygosity in Europe. In
general, ascertainment bias is expected to be very modest for
microsatellites because low-heterozygosity microsatellites are quite
rare [62,64,77]. As Rosenberg et al. [64] note, their microsatellite data
are very similar to data from microsatellites ascertained in
independent, geographically diverse panels. Nevertheless, we must
consider the possibility that ascertainment bias contributes to the
shapes of the empirical lnRV and lnRH distributions. The expected
effect of ascertainment bias is the truncation of the left tails of the
distributions, due to the exclusion of loci with low heterozygosity in
Europeans, and consequently the extension of the right tails. Two
predictions are thus a departure from normality and a signiﬁcantly
positive skew, measured by the third moment about the mean. As
noted, all lnRV distributions are consistent with normality and have
well-behaved tail probabilities. Only the Ethiopian lnRV distribution
has a signiﬁcantly positive skew. For lnRH, four of ﬁve distributions
fail the Kolmogorov-Smirnov test for normality, but the departures
appear to be due largely to elevated kurtosis, not to positive skew.
Only the Italian distribution has a signiﬁcantly positive skew. We can
construct a conservative test by drawing p-values from the right tails
of the lnRh distributions, which should be enlarged relative to the
unbiased case; all lnRh values are as extreme relative to the right tails
as to the left, except for Ethiopian lnRh values, whose p-values rise to
0.016 (lnRH) and 0.119 (lnRV). Because lnRH has a smaller coalescent
variance than lnRV, lnRH is exquisitely sensitive to selection [63],
and the observed departures from normality may therefore simply
reﬂect the occurrence of selection at sites linked to some subset of
the 377 loci [65,78]. The complete microsatellite dataset is presented
in Table S2.
Supporting Information
Figure S1. Intensity of Positive Selection
The average selection coefﬁcient (s) of advantageous mutations can
be estimated from the rate acceleration of the human 68-bp element,
conditioned on the fractions of all mutations that are advantageous,
neutral, and deleterious. When the advantageous fraction is more
than 2.5%, the average selection coefﬁcient is less than 0.01. Over
most of the parameter space, s is less than 0.001. The red line
illustrates the case in which all and only the ﬁve ﬁxed mutations are
advantageous.
Found at DOI: 10.1371/journal.pbio.0030387.sg001 (1.7 MB EPS).
Table S1. Experimentally Determined PDYN Haplotypes from 74
Austrian Chromosomes
Each unique haplotype is shown, from a sample of chromosomes
selected to overrepresent the rare one- and four-repeat alleles.
Derived alleles are highlighted in red. Haplotypes were determined
by complete sequencing of multiple clones of each allele. Msat refers
to the CAn microsatellite 1.3 kb upstream of the 68-bp repeat.
Position 2370 segregates TC7 and TC9 alleles. The ancestral states at
Msat and 2370 are uncertain, as both sites vary among and within the
other primate species.
Found at DOI: 10.1371/journal.pbio.0030387.st001 (74 KB PDF).
Table S2. Microsatellite Summary Statistics
For the PDYN microsatellite and those used to generate the genome-
wide empirical distributions, we report the sample sizes, expected
heterozygosities, and repeat-number variances, as well as the test
statistics lnRH and lnRV.
Found at DOI: 10.1371/journal.pbio.0030387.st002 (223 KB XLS).
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